SCHEMBL9650411

SCHEMBL9650411

Cc1ccc(C2=CC(F)=CC[CH]2)cc1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.34
NFE2L2 Q16236 1/20 0.32
TDP1 Q9NUW8 1/20 0.31
PTGS1 P23219 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4805089 0.77 TDP1 (0.34) ACHETDP1
SCHEMBL4806936 0.76 ACHE (0.35) ACHE
SCHEMBL4804521 0.70 LMNA (0.35) TDP1
SCHEMBL4809916 0.69 MAPK1 (0.38) TDP1
SCHEMBL4804592 0.68 KDM4E (0.32)
SCHEMBL9650425 0.68 CHRNB4 (0.35)
SCHEMBL2545284 0.68
SCHEMBL16817006 0.67 TDP1 (0.36) ACHETDP1
SCHEMBL5180094 0.64 ALDH1A1 (0.32)
SCHEMBL4008031 0.63 ALDH1A1 (0.39) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5120848-A Anticholesterol and antilipemic agents; hydroxy-3-methylglutaryl/3-/ coenzyme A reductase inhibitors GLAXO GROUP LIMITED (GB) 1992-06-09 US disclosed
US-5013749-A Imidazole derivatives and their use as hypercholesterolemia and hyperlipoproteinemia agents GLAXO GROUP LIMITED (GB) 1991-05-07 US disclosed